Catalyst Wire Dossier Catalyst Wire Dossier

Albumin Interferon

· Novartis
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Albumin Interferon, covering 2016-11-16 to 2016-11-16. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy of Albumin Interferon Administered Every 4 Weeks in Genotype 2/3 Hepatitis C Patients [Phase 2]

See pricing